HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark R Albertini Selected Research

Dacarbazine (DIC)

6/2014Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark R Albertini Research Topics

Disease

34Melanoma (Melanoma, Malignant)
01/2021 - 07/2003
19Neoplasms (Cancer)
01/2022 - 06/2003
4Hypotension (Low Blood Pressure)
12/2012 - 11/2004
3Lymphocytosis
12/2012 - 11/2004
3Neuroblastoma
11/2010 - 03/2006
3Hypersensitivity (Allergy)
11/2010 - 07/2006
2Exanthema (Rash)
01/2021 - 11/2010
2Uveal melanoma
03/2017 - 06/2014
2Disease Progression
06/2014 - 06/2012
2Residual Neoplasm
12/2012 - 07/2009
2Hypoxia (Hypoxemia)
11/2010 - 11/2004
2Pain (Aches)
11/2010 - 07/2006
2Hyperbilirubinemia
11/2010 - 11/2004
1Body Remains
01/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
01/2022
1Brain Neoplasms (Brain Tumor)
01/2021
1Osteosarcoma (Osteogenic Sarcoma)
01/2021
1Carcinoma (Carcinomatosis)
01/2019
1Lymphatic Metastasis
01/2016
1Necrosis
01/2016
1Ataxia Telangiectasia (Louis Bar Syndrome)
03/2013
1Renal Insufficiency (Renal Failure)
12/2012
1Oliguria
12/2012
1Chills
06/2012
1Nausea
06/2012
1Hemangiosarcoma (Angiosarcoma)
06/2012
1Vomiting
06/2012
1Testicular Neoplasms (Testicular Cancer)
10/2007
1Experimental Melanoma
02/2007
1Sarcoma (Soft Tissue Sarcoma)
07/2006

Drug/Important Bio-Agent (IBA)

9AntigensIBA
01/2020 - 07/2004
8lorukafusp alfaIBA
01/2021 - 11/2004
7Monoclonal AntibodiesIBA
06/2012 - 06/2003
4IpilimumabIBA
01/2021 - 01/2018
4DNA (Deoxyribonucleic Acid)IBA
08/2017 - 07/2003
4Interleukin-2 (IL2)IBA
11/2010 - 03/2006
3Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA
01/2022 - 12/2008
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2020
3VaccinesIBA
12/2020 - 02/2009
3Immune Checkpoint InhibitorsIBA
11/2020 - 01/2019
3Thioguanine (Tioguanine)FDA Link
01/2020 - 12/2008
3Neoplasm Antigens (Tumor Antigens)IBA
01/2016 - 07/2004
2InterferonsIBA
01/2021 - 03/2017
2AZD 6244IBA
03/2017 - 06/2014
2GlycolipidsIBA
01/2016 - 01/2010
2Transaminases (Aminotransferases)IBA
11/2010 - 11/2004
2Proteins (Proteins, Gene)FDA Link
11/2010 - 06/2003
2Dopamine (Intropin)FDA LinkGeneric
11/2010 - 03/2006
2EpitopesIBA
01/2010 - 02/2009
2CytokinesIBA
02/2009 - 06/2003
2Paclitaxel (Taxol)FDA LinkGeneric
08/2008 - 10/2005
2Interleukin-2 Receptors (IL 2 Receptor)IBA
03/2006 - 11/2004
1Capsules (Microcapsules)IBA
01/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2021
1Radioisotopes (Radionuclides)IBA
01/2021
1alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA
01/2020
1Tumor Biomarkers (Tumor Markers)IBA
01/2020
1Interferon alpha-2 (Roferon-A)FDA Link
01/2020
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1NivolumabIBA
01/2018
1DNA VaccinesIBA
08/2017
1Monophenol Monooxygenase (Tyrosinase)IBA
08/2017
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2017
1Temozolomide (Temodar)FDA LinkGeneric
06/2014
1Dacarbazine (DIC)FDA LinkGeneric
06/2014
1Adenosine Triphosphate (ATP)IBA
06/2014
1Mitogen-Activated Protein KinasesIBA
06/2014
1HeterochromatinIBA
03/2013
1Phosphotransferases (Kinase)IBA
03/2013
1C-Reactive ProteinIBA
12/2012
1IntegrinsIBA
06/2012
1intetumumabIBA
06/2012
1Indicators and Reagents (Reagents)IBA
02/2011
1AcidsIBA
02/2011
1Melanoma-Specific AntigensIBA
02/2011
1Immunoglobulins (Immunoglobulin)IBA
01/2010
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
02/2009
1Protein Subunit VaccinesIBA
02/2009
1Interferon-alpha2bIBA
02/2009
1Complementarity Determining Regions (Complementarity Determining Region)IBA
12/2008
1Sorafenib (BAY 43-9006)FDA Link
08/2008
1Carboplatin (JM8)FDA LinkGeneric
08/2008
1Immunoglobulin G (IgG)IBA
10/2007
1AutoantigensIBA
02/2007
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2007
1Peptides (Polypeptides)IBA
01/2007
1AntibodiesIBA
07/2006

Therapy/Procedure

13Therapeutics
01/2021 - 10/2005
8Immunotherapy
11/2020 - 07/2004
3Injections
01/2021 - 01/2010
3Drug Therapy (Chemotherapy)
03/2017 - 03/2013
2Radiotherapy
01/2021 - 01/2021
1Transplantation
01/2022
1Precision Medicine
01/2021
1Lymph Node Excision (Lymph Node Dissection)
01/2021
1Chemoprevention
01/2019
1Intravenous Infusions
12/2012
1Drug Tapering
12/2012